Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed at $7.47 in the last session, up 0.67% from day before closing price of $7.42. In other words, the price has increased by $0.67 from its previous closing price. On the day, 2.35 million shares were traded. BCRX stock price reached its highest trading level at $7.61 during the session, while it also had its lowest trading level at $7.3.
Ratios:
We take a closer look at BCRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.48 and its Current Ratio is at 3.73.
On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.
Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 24 ’24 when McKee Amy E sold 8,600 shares for $6.32 per share. The transaction valued at 54,352 led to the insider holds 27,831 shares of the business.
SANDERS MACHELLE sold 4,689 shares of BCRX for $28,134 on Jun 17 ’24. The Director now owns 27,742 shares after completing the transaction at $6.00 per share. On Jun 14 ’24, another insider, HEGGIE THERESA, who serves as the Director of the company, sold 6,698 shares for $6.11 each. As a result, the insider received 40,925 and left with 52,852 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1541636096 and an Enterprise Value of 2057982848. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.34. Its current Enterprise Value per Revenue stands at 5.791 whereas that against EBITDA is -25.071.
Stock Price History:
The Beta on a monthly basis for BCRX is 1.89, which has changed by -0.056818187 over the last 52 weeks, in comparison to a change of 0.21656322 over the same period for the S&P500. Over the past 52 weeks, BCRX has reached a high of $7.95, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is 16.13%, while the 200-Day Moving Average is calculated to be 30.37%.
Shares Statistics:
According to the various share statistics, BCRX traded on average about 3.64M shares per day over the past 3-months and 2844540 shares per day over the past 10 days. A total of 205.77M shares are outstanding, with a floating share count of 198.09M. Insiders hold about 4.01% of the company’s shares, while institutions hold 86.40% stake in the company. Shares short for BCRX as of 1719532800 were 17880493 with a Short Ratio of 4.92, compared to 1717113600 on 36183606. Therefore, it implies a Short% of Shares Outstanding of 17880493 and a Short% of Float of 8.74.
